Glenn HearsonJul 30, 2020Summer 2020 Asthma Newsletter Including Synairgen COVID-19 drug Trial success and Patient StoryThe summer 2020 Asthma Newsletter is now out. This edition includes news about the success of the Synairgen SNG001 Interferon-β #COVID-19 research and one patients experience of being in the trial.NAC Newsletter Summer 2020.pdfDownload PDF • 951KBE-Newsletter below and PDF available for download
The summer 2020 Asthma Newsletter is now out. This edition includes news about the success of the Synairgen SNG001 Interferon-β #COVID-19 research and one patients experience of being in the trial.NAC Newsletter Summer 2020.pdfDownload PDF • 951KBE-Newsletter below and PDF available for download
Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)
Study to evaluate the safety, pharmacokinetics and pharmacodynamics of Selnofast in participants with moderate to severe Asthma